For the quarter ending 2026-03-31, GDRX made $194,006K in revenue. $1,169K in net income. Net profit margin of 0.60%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 194,006 | 194,785 | 196,028 | 203,070 |
| Cost of revenue, exclusive of depreciation and amortization presented separately below | 20,156 | 17,464 | 13,419 | 13,350 |
| Product development and technology | 30,177 | 28,939 | 31,012 | 29,933 |
| Sales and marketing | 81,053 | 78,616 | 83,532 | 84,870 |
| General and administrative | 26,819 | 23,937 | 32,014 | 28,379 |
| Depreciation and amortization | 21,792 | 23,146 | 21,431 | 19,729 |
| Total costs and operating expenses | 179,997 | 172,102 | 181,408 | 176,261 |
| Operating income | 14,009 | 22,683 | 14,620 | 26,809 |
| Other income (expense) | - | 24* | 0 | 694 |
| Loss on extinguishment of debt | - | 0* | 0 | - |
| Interest income | 1,397 | 1,889 | 2,309 | 2,803 |
| Interest expense | 9,767 | 10,403 | 10,829 | 10,729 |
| Total other expense, net | -8,370 | -8,490 | -8,520 | -7,232 |
| Income before income taxes | 5,639 | 14,193 | 6,100 | 19,577 |
| Income tax expense | 4,470 | 8,768 | 4,981 | 6,734 |
| Net income | 1,169 | 5,425 | 1,119 | 12,843 |
| Basic EPS | 0 | 0.016 | 0 | 0.04 |
| Diluted EPS | 0 | 0.016 | 0 | 0.04 |
| Basic Average Shares | 340,531,000 | 342,713,000 | 346,776,000 | 356,623,000 |
| Diluted Average Shares | 341,424,000 | 343,267,000 | 347,810,000 | 357,159,000 |
GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. (GDRX)